Inside the science of vape flavours
Debate – and even regulation – around flavoured vapes is often dominated by binary narratives built on emotions and ideologies rather than data. Imperial Brand’s new peer-reviewed literature review draws from over 230 published studies to help separate fact from feelings… and fiction. Here, some of the review’s most important findings are explored.
Responsibly manufactured flavours don’t enhance toxicological or inhalation risks
A central concern often raised about flavoured vaping products is whether flavour ingredients, like fruit and mint, result in additional inhalation risks compared with tobacco flavours. However, the review demonstrates there’s no robust scientific evidence that non-tobacco flavours, when properly formulated and tested, present any greater toxicological risk than tobacco flavours.
Most toxicology studies that report elevated risks use unrealistic conditions, such as excessive temperatures, over-concentrated flavouring agents, or direct chemical exposure – rather than aerosol generation that reflects real-world conditions. When experiments are conducted under realistic device settings and puff topography, toxicological markers remain substantially lower than those seen with cigarette smoke.
Indeed, research like this study in Toxicity In Vitro shows significant reductions in cytotoxicity were observed for a range of flavoured vapes ranging from 143 to 1191 times less toxic than cigarettes – and no discernible genotoxic or mutagenic effects at all.
These findings firmly underscore the importance of context. Inhalation safety depends not only on flavour compounds’ chemical identity, but, critically, also on product design, formulation, aerosol generation parameters, and realistic exposure conditions.
Flavours aren’t the primary driver of vape dependence
Concerns that non-tobacco flavoured vapes might enhance nicotine dependence or abuse liability are widespread, albeit largely unfounded according to the scientific data so far. There is no convincing evidence that sweets, fruity, or minty flavoured vapes increase dependence, relative to tobacco-flavoured ones.
Instead, nicotine remains the principal driver of dependence – not flavour. Conflating flavour attractiveness with dependence overlooks the pharmacological realities and therefore risks undermining evidence-based regulation.
Flavours support switching
One of the most significant regulatory and public health considerations relates to the role of flavoured vapes in helping adult individuals who smoke reduce their cigarette consumption. Our review identifies consistent evidence that many adult smokers prefer non-tobacco flavours when switching, and this underpins sustained cigarette abstinence.
For example, this study on PubMed from Harm Reduction Journal looked at 69,233 adult vapers and found that the most prevalent flavour at the time of smoking cessation was fruit at over 83% It also found that tobacco flavour use prevalence was low and further reduced over time, emphasising the role flavours may play in long-term public health strategies.
Given that smoking remains a leading cause of preventable disease globally, maintaining vape flavour diversity may therefore potentially contribute substantially to reducing smoking prevalence[1].
Vape flavours regulation and policy
Bans on non-tobacco flavoured vapes may seem precautionary and are generally well-intentioned, but the scientific evidence and studies to-date show they can have unintended negative consequences. For example, evidence suggests such bans may reduce vaping’s appeal to adult smokers. This undermines switching and, in some states and countries, has increased cigarette smoking or illicit vape use.
From a regulatory-science perspective, a more balanced, evidence-based approach is needed – one that prioritises facts over feelings, encouraging data-driven decision making. It should protect youth and unintended users, but also preserve flavour diversity and enforce responsible product stewardship to better support adult smokers seeking a reduced-risk alternative.
Our literature review highlights that, when responsible formulation, realistic testing, and context-based risk assessment are applied, flavoured vapes can help drive meaningful public health benefits.
Nevertheless, the paper also underscores the need for continued research, including long-term inhalation studies, independent toxicological assessment, and rigorous real-world surveillance to continue to build the existing weight-of-evidence.
For scientific audiences, public health bodies, regulators and governments, the ultimate message is clear: scientific evidence should guide policy – not assumptions and feelings, and any accompanying myths and misconceptions should be firmly debunked through impactful public health communications.
For more insight on what scientific evidence says about the relationship between flavoured vapes and THR, read our infographic below and find our literature review, Flavoured Vaping Products in Tobacco Harm Reduction: A Regulatory Perspective, in full here.
[1] Our vapes are not licensed cessation products, nor marketed as such.